Spearhead Capital Advisors’s Karyopharm Therapeutics KPTI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,297	Closed	-$222K	–	214
2021 Q4	$222K	Buy	2,297 +53	+2%	+$5.12K	0.03%	166
2021 Q3	$196K	Sell	2,244 -25	-1%	-$2.18K	0.03%	183
2021 Q2	$351K	Buy	2,269 +467	+26%	+$72.2K	0.05%	165
2021 Q1	$284K	Buy	+1,802	New	+$284K	0.04%	170